Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
Adithya Hande, Head of Clinical Projects at DERBI Foundation, shared a post on LinkedIn:
”India’s Silent Killer — and a Scientific Breakthrough You Need to Know About
Thrombosis-related diseases (like pulmonary embolism, stroke, and DVT) are quietly responsible for millions of hospitalizations and deaths in India each year — especially post-COVID.
Yet, we’re still relying on decades-old anticoagulants with dangerous side effects like internal bleeding and poor patient adherence.
But what if we could prevent clots safely, without disrupting the body’s natural healing?
Scientists at IISc have developed a game-changing nanozyme that mimics antioxidant enzymes — a first-of-its-kind, bleeding-free clot therapy.
This article dives into:
- What makes this science revolutionary
- The current treatment challenges for thrombosis in India
- Market gaps ripe for startup innovation
- Why this could be a deeptech goldmine for healthcare entrepreneurs
Click below to read the full breakdown — from a healthcare innovation lens.”

Stay updated with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD
